TNNT2 and non-small cell lung carcinoma: Therefore, we evaluated the clinical value of cTnT indicating pre-clinical cardiovascular injury in NSCLC patients through ROC curve (the cutoff point was 0.0105 ng/m, while the AUC value was 0.720).